These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9972133)

  • 1. Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells.
    Hanemaaijer R; Visser H; Koolwijk P; Sorsa T; Salo T; Golub LM; van Hinsbergh VW
    Adv Dent Res; 1998 Nov; 12(2):114-8. PubMed ID: 9972133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines.
    Ramamurthy NS; Rifkin BR; Greenwald RA; Xu JW; Liu Y; Turner G; Golub LM; Vernillo AT
    J Periodontol; 2002 Jul; 73(7):726-34. PubMed ID: 12146531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of chemically modified tetracyclines (CMTs) on human keratinocyte proliferation and migration.
    Mäkelä M; Sorsa T; Uitto VJ; Salo T; Teronen O; Larjava H
    Adv Dent Res; 1998 Nov; 12(2):131-5. PubMed ID: 9972137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of proteolytic, serpinolytic, and progelatinase-b activation activities of periodontopathogens by doxycycline and the non-antimicrobial chemically modified tetracycline derivatives.
    Grenier D; Plamondon P; Sorsa T; Lee HM; McNamara T; Ramamurthy NS; Golub LM; Teronen O; Mayrand D
    J Periodontol; 2002 Jan; 73(1):79-85. PubMed ID: 11846203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetracycline-based MMP inhibitors can prevent fibroblast-mediated collagen gel contraction in vitro.
    Myers SA; Wolowacz RG
    Adv Dent Res; 1998 Nov; 12(2):86-93. PubMed ID: 9972128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxycycline and chemically modified tetracyclines inhibit gelatinase A (MMP-2) gene expression in human skin keratinocytes.
    Uitto VJ; Firth JD; Nip L; Golub LM
    Ann N Y Acad Sci; 1994 Sep; 732():140-51. PubMed ID: 7978787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of chemically modified tetracyclines (CMTs) in experimental models of cancer and arthritis.
    Seftor EA; Seftor RE; Nieva DR; Hendrix MJ
    Adv Dent Res; 1998 Nov; 12(2):103-10. PubMed ID: 9972131
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacologic suppression of experimental abdominal aortic aneurysms: acomparison of doxycycline and four chemically modified tetracyclines.
    Curci JA; Petrinec D; Liao S; Golub LM; Thompson RW
    J Vasc Surg; 1998 Dec; 28(6):1082-93. PubMed ID: 9845660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms.
    Golub LM; Lee HM; Ryan ME; Giannobile WV; Payne J; Sorsa T
    Adv Dent Res; 1998 Nov; 12(2):12-26. PubMed ID: 9972117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline.
    Hanemaaijer R; Sorsa T; Konttinen YT; Ding Y; Sutinen M; Visser H; van Hinsbergh VW; Helaakoski T; Kainulainen T; Rönkä H; Tschesche H; Salo T
    J Biol Chem; 1997 Dec; 272(50):31504-9. PubMed ID: 9395486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester.
    Hanemaaijer R; Koolwijk P; le Clercq L; de Vree WJ; van Hinsbergh VW
    Biochem J; 1993 Dec; 296 ( Pt 3)(Pt 3):803-9. PubMed ID: 8280080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential patterns of response to doxycycline and transforming growth factor beta1 in the down-regulation of collagenases in osteoarthritic and normal human chondrocytes.
    Shlopov BV; Smith GN; Cole AA; Hasty KA
    Arthritis Rheum; 1999 Apr; 42(4):719-27. PubMed ID: 10211886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model.
    Lokeshwar BL; Selzer MG; Zhu BQ; Block NL; Golub LM
    Int J Cancer; 2002 Mar; 98(2):297-309. PubMed ID: 11857423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemically modified tetracyclines stimulate matrix metalloproteinase-2 production by periodontal ligament cells.
    Bildt MM; Snoek-Van Beurden AM; DeGroot J; Van El B; Kuijpers-Jagtman AM; Von den Hoff JW
    J Periodontal Res; 2006 Oct; 41(5):463-70. PubMed ID: 16953823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats.
    Castro MM; Rizzi E; Figueiredo-Lopes L; Fernandes K; Bendhack LM; Pitol DL; Gerlach RF; Tanus-Santos JE
    Atherosclerosis; 2008 Jun; 198(2):320-31. PubMed ID: 18054360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase production by cultured human endometrial stromal cells: identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1 alpha and tumor necrosis factor-alpha.
    Rawdanowicz TJ; Hampton AL; Nagase H; Woolley DE; Salamonsen LA
    J Clin Endocrinol Metab; 1994 Aug; 79(2):530-6. PubMed ID: 8045973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
    Mackay AR; Ballin M; Pelina MD; Farina AR; Nason AM; Hartzler JL; Thorgeirsson UP
    Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential application of a chemically modified non-antimicrobial tetracycline (CMT-3) against metastatic prostate cancer.
    Lokeshwar BL; Houston-Clark HL; Selzer MG; Block NL; Golub LM
    Adv Dent Res; 1998 Nov; 12(2):97-102. PubMed ID: 9972130
    [No Abstract]   [Full Text] [Related]  

  • 19. Dose-response effect of tetracyclines on cerebral matrix metalloproteinase-9 after vascular endothelial growth factor hyperstimulation.
    Lee CZ; Yao JS; Huang Y; Zhai W; Liu W; Guglielmo BJ; Lin E; Yang GY; Young WL
    J Cereb Blood Flow Metab; 2006 Sep; 26(9):1157-64. PubMed ID: 16395286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemically modified tetracyclines act through multiple mechanisms directly on osteoclast precursors.
    Holmes SG; Still K; Buttle DJ; Bishop NJ; Grabowski PS
    Bone; 2004 Aug; 35(2):471-8. PubMed ID: 15268899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.